Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy.
Thelen M, Wennhold K, Lehmann J, Garcia-Marquez M, Klein S, Kochen E, Lohneis P, Lechner A, Wagener-Ryczek S, Plum PS, Velazquez Camacho O, Pfister D, Dörr F, Heldwein M, Hekmat K, Beutner D, Klussmann JP, Thangarajah F, Ratiu D, Malter W, Merkelbach-Bruse S, Bruns CJ, Quaas A, von Bergwelt-Baildon M, Schlößer HA. Thelen M, et al. NPJ Precis Oncol. 2021 Jun 16;5(1):52. doi: 10.1038/s41698-021-00196-x. NPJ Precis Oncol. 2021. PMID: 34135436 Free PMC article.
MDM2 gene amplification in esophageal carcinoma.
Michalk M, Meinrath J, Künstlinger H, Koitzsch U, Drebber U, Merkelbach-Bruse S, Bollschweiler E, Kloth M, Hartmann W, Hölscher A, Quaas A, Grimminger PP, Odenthal M. Michalk M, et al. Oncol Rep. 2016 Apr;35(4):2223-7. doi: 10.3892/or.2016.4578. Epub 2016 Jan 20. Oncol Rep. 2016. PMID: 26796597
Therapy susceptible germline-related BRCA 1-mutation in a case of metastasized mixed adeno-neuroendocrine carcinoma (MANEC) of the small bowel.
Quaas A, Waldschmidt D, Alakus H, Zander T, Heydt C, Goeser T, Daheim M, Kasper P, Plum P, Bruns C, Brunn A, Roth W, Hartmann N, Bunck A, Schmidt M, Göbel H, Tharun L, Buettner R, Merkelbach-Bruse S. Quaas A, et al. BMC Gastroenterol. 2018 May 31;18(1):75. doi: 10.1186/s12876-018-0803-1. BMC Gastroenterol. 2018. PMID: 29855275 Free PMC article.
Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence.
Pasternack H, Fassunke J, Plum PS, Chon SH, Hescheler DA, Gassa A, Merkelbach-Bruse S, Bruns CJ, Perner S, Hallek M, Büttner R, Bollschweiler E, Hölscher AH, Quaas A, Zander T, Weiss J, Alakus H. Pasternack H, et al. Sci Rep. 2018 Oct 8;8(1):14941. doi: 10.1038/s41598-018-33027-4. Sci Rep. 2018. PMID: 30297788 Free PMC article.
Genomic Characterization of TP53-Wild-Type Esophageal Carcinoma.
Quaas A, Heydt C, Gebauer F, Alakus H, Loeser H, Buettner R, Hillmer A, Bruns C, Merkelbach-Bruse S, Zander T, Frommolt P. Quaas A, et al. Transl Oncol. 2019 Jan;12(1):154-161. doi: 10.1016/j.tranon.2018.09.007. Epub 2018 Oct 11. Transl Oncol. 2019. PMID: 30317074 Free PMC article.
Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma.
Wagener-Ryczek S, Schoemmel M, Kraemer M, Bruns C, Schroeder W, Zander T, Gebauer F, Alakus H, Merkelbach-Bruse S, Buettner R, Loeser H, Thelen M, Schlößer HA, Quaas A. Wagener-Ryczek S, et al. Cancer Immunol Immunother. 2020 Apr;69(4):523-533. doi: 10.1007/s00262-019-02475-w. Epub 2020 Jan 20. Cancer Immunol Immunother. 2020. PMID: 31960110 Free PMC article.
205 results